Wednesday, August 05, 2020 7:52:21 AM
Short DD overview for potential investors:
Market cap:
$34M
Cash on hand:
$22M
Oustanding shares after offering: 3.2M shares
Starting a Phase 3 in the US for a drug called cytisinicline that helps smokers quit.
Drug is already used for years in Europe (20 million people have used it there).
Other competitor already in the Market is Chantrix, its market is about $1.2B.
ACHV just registered a patent related to this drug and is about to launch a Phase 3 by years end. Given the extensive use in Europe, Approval is almost guaranteed.
Here under you'll find a link to an article related to a Phase 3 trial for cytisinicline in New-Zealand showing non-inferiority to Chantrix and lower side effects.
https://scr.zacks.com/News/Press-Releases/Press-Release-Details/2020/ACHV-RAUORA-Cytisiniclines-Superior-Side-Effect-Profile/default.aspx
Results of New-Zealand Phase 3 trials to be officially presented in september.
If they get just 15% of Chantrix market, with a p/s ratio of only 1, MC -->
$180M
--> a 5 bagger for a drug already heavily used in Europe.
Recent ACHV News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 08:39:30 PM
- Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors • GlobeNewswire Inc. • 08/26/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:11:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:07:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:05:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:08:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:06:08 PM
- Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update • GlobeNewswire Inc. • 08/13/2024 08:01:00 PM
- Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence • GlobeNewswire Inc. • 07/31/2024 12:00:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 12:10:11 PM
- Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024 • GlobeNewswire Inc. • 07/25/2024 12:00:00 PM
- Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024 • GlobeNewswire Inc. • 07/09/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/09/2024 04:15:14 AM
- Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes • GlobeNewswire Inc. • 07/01/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 09:07:23 PM
- Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 05/20/2024 09:01:27 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/17/2024 06:56:31 PM
- Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting • GlobeNewswire Inc. • 05/17/2024 12:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:08:41 PM
- Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 08:01:28 PM
- Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine • GlobeNewswire Inc. • 05/06/2024 03:16:04 PM
- Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024 • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM